Boqing Wang

916 total citations
23 papers, 330 citations indexed

About

Boqing Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Boqing Wang has authored 23 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Boqing Wang's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Boqing Wang is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Boqing Wang collaborates with scholars based in China, Ethiopia and Japan. Boqing Wang's co-authors include Wei Zhao, Tiebang Kang, Yuanzhong Wu, Ruhua Zhang, Yi Sang, Jianwen Liu, Haibo Han, Zhihua Tian, Jianjun Tang and Bo Ma and has published in prestigious journals such as British Journal of Cancer, Medicine and Annals of Surgical Oncology.

In The Last Decade

Boqing Wang

21 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boqing Wang China 10 219 121 56 50 26 23 330
Youguang Huang China 10 230 1.1× 132 1.1× 86 1.5× 38 0.8× 20 0.8× 20 353
Yuandeng Luo China 8 184 0.8× 90 0.7× 53 0.9× 67 1.3× 30 1.2× 12 285
Qiaohong Qin China 11 248 1.1× 190 1.6× 61 1.1× 44 0.9× 41 1.6× 23 416
Jiming Bao China 9 228 1.0× 78 0.6× 53 0.9× 49 1.0× 34 1.3× 22 373
Liye Fu China 11 216 1.0× 91 0.8× 30 0.5× 72 1.4× 13 0.5× 18 300
Yuanhong Wu China 8 170 0.8× 93 0.8× 55 1.0× 65 1.3× 30 1.2× 20 438
Yiming Xu China 11 195 0.9× 142 1.2× 44 0.8× 19 0.4× 14 0.5× 30 338
Huiting Zhong China 6 182 0.8× 80 0.7× 19 0.3× 52 1.0× 23 0.9× 11 279
Debanjali Dasgupta United States 11 255 1.2× 192 1.6× 32 0.6× 30 0.6× 32 1.2× 27 421

Countries citing papers authored by Boqing Wang

Since Specialization
Citations

This map shows the geographic impact of Boqing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boqing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boqing Wang more than expected).

Fields of papers citing papers by Boqing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boqing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boqing Wang. The network helps show where Boqing Wang may publish in the future.

Co-authorship network of co-authors of Boqing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Boqing Wang. A scholar is included among the top collaborators of Boqing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boqing Wang. Boqing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Kai, Xin Li, Chen Liu, et al.. (2025). RNA binding motif protein 25 is a negative prognostic biomarker and promotes cell proliferation via alternative splicing in hepatocellular carcinoma. Pathology - Research and Practice. 269. 155941–155941.
2.
Xie, Fei, Xiaohu Wen, Ruping Zhao, et al.. (2024). GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma. Pharmacological Research. 210. 107490–107490. 9 indexed citations
3.
4.
5.
Wang, Boqing, Jianjun Tang, Dan Liao, et al.. (2021). Correction to: Chromobox Homolog 4 is Correlated with Prognosis and Tumor Cell Growth in Hepatocellular Carcinoma. Annals of Surgical Oncology. 28(S3). 885–886. 2 indexed citations
6.
Zhao, Wei, Bo Ma, Zhihua Tian, et al.. (2021). Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance. British Journal of Cancer. 124(7). 1237–1248. 26 indexed citations
7.
Yan, Qian, et al.. (2020). A network meta-analysis. Medicine. 99(31). e20500–e20500. 3 indexed citations
8.
Yan, Qian, et al.. (2019). Argon–helium cryoablation for liver carcinoma in high-risk locations: Safety and efficacy. Cryobiology. 90. 8–14. 4 indexed citations
9.
Li, Yifan, Bao Guan, Jianwen Liu, et al.. (2019). MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. EBioMedicine. 44. 439–451. 48 indexed citations
10.
Yang, Min, Jianwen Liu, Fei Wang, et al.. (2019). Lysyl oxidase assists tumor‑initiating cells to enhance angiogenesis in hepatocellular carcinoma. International Journal of Oncology. 54(4). 1398–1408. 25 indexed citations
11.
12.
Guo, Jiao, Xinhua Huang, & Boqing Wang. (2017). MyCOS Intelligent Teaching Assistant.. Educational Data Mining. 1 indexed citations
13.
Xue, Feng, et al.. (2017). MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6. Experimental and Therapeutic Medicine. 13(6). 2667–2674. 15 indexed citations
14.
Tang, Jintian, Chunyan Xu, Feng Xue, et al.. (2017). EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Oncology Reports. 38(4). 2251–2258. 12 indexed citations
15.
Lin, Tong, et al.. (2017). Baduanjin Exercise for Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2017(1). 8378219–8378219. 29 indexed citations
16.
Lin, Xu, Feng Xue, Boqing Wang, et al.. (2016). Hoarseness due to lymph node metastasis of hepatocellular carcinoma: A case report. Oncology Letters. 12(2). 918–920. 2 indexed citations
17.
Tang, Jianjun, Gang Wang, Meifang Zhang, et al.. (2014). Paradoxical role of CBX8 in proliferation and metastasis of colorectal cancer. Oncotarget. 5(21). 10778–10790. 45 indexed citations
18.
Tang, Jianjun, Shaoyan Xi, Gang Wang, et al.. (2013). Prognostic significance of BRCA1-associated protein 1 in colorectal cancer. Medical Oncology. 30(2). 541–541. 30 indexed citations
19.
Wang, Boqing, Jianjun Tang, Dan Liao, et al.. (2013). Chromobox Homolog 4 Is Correlated with Prognosis and Tumor Cell Growth in Hepatocellular Carcinoma. Annals of Surgical Oncology. 20(S3). 684–692. 50 indexed citations
20.
Liu, Gordon G., et al.. (1999). Urban Health Care Reform Initiative in China: Findings from Its Pilot Experiment in Zhengjiang City (1). 1(4). 504. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youguang Huang Breakdown of academic impact, for papers by Yuandeng Luo Breakdown of academic impact, for papers by Qiaohong Qin Breakdown of academic impact, for papers by Jiming Bao Breakdown of academic impact, for papers by Liye Fu Breakdown of academic impact, for papers by Yuanhong Wu Breakdown of academic impact, for papers by Yiming Xu Breakdown of academic impact, for papers by Huiting Zhong Breakdown of academic impact, for papers by Debanjali Dasgupta
Rankless by CCL
2026